What does a hemoglobin of 17.3 g/dL and hematocrit (packed cell volume) of 53.8% with facial swelling indicate, and how should it be evaluated and managed?

Elevated Hemoglobin and Hematocrit with Facial Swelling

This presentation requires urgent evaluation for polycythemia vera (PV) with JAK2 mutation testing and assessment for superior vena cava syndrome or thrombotic complications, as the Hb 17.3 g/dL and hematocrit 53.8% exceed WHO 2016 diagnostic thresholds for PV, and facial swelling may indicate venous obstruction or thrombosis—a life-threatening complication of myeloproliferative neoplasms.

Immediate Clinical Concerns

The combination of markedly elevated red cell parameters with facial swelling is particularly concerning for:

• Thrombotic complications: PV patients have significantly increased thrombosis risk, and facial swelling could indicate superior vena cava obstruction, cerebral venous thrombosis, or other venous thrombotic events 1
• Hyperviscosity syndrome: The hematocrit of 53.8% places blood viscosity in a range that impairs tissue oxygen delivery and increases thrombotic risk

Diagnostic Approach

Step 1: Assess the Polycythemia

The hemoglobin of 17.3 g/dL and hematocrit of 53.8% exceed the WHO 2016 major diagnostic criteria for PV 2:

• Men: Hb >16.5 g/dL or Hct >49%
• Women: Hb >16.0 g/dL or Hct >48%

However, a critical caveat: These values overlap with the upper range of normal in some populations, with up to 6.48% of men having Hb >16.5 g/dL or Hct >49% in routine screening 3. Therefore, do not diagnose PV based on these numbers alone.

Step 2: Order JAK2 Mutation Testing Immediately

JAK2V617F mutation testing is the second major criterion and should be ordered urgently 4. The presence of both elevated Hb/Hct AND JAK2 mutation captures >97% of PV cases 4.

Step 3: Evaluate the Facial Swelling

The facial swelling requires immediate imaging to rule out:

• Superior vena cava syndrome (contrast-enhanced CT chest/neck)
• Cerebral venous thrombosis (MRI brain with venography if neurologic symptoms present)
• Orbital/periorbital thrombosis (contrast-enhanced CT or MRI orbits) 5

This is critical because thrombosis can be the presenting feature of masked PV, even with normal blood counts, and carries poor prognosis 1.

Step 4: Complete the Diagnostic Workup

To meet WHO 2016 criteria, you need both major criteria plus at least one minor criterion 2:

Minor criteria to obtain:

1. Bone marrow biopsy: Look for hypercellularity with trilineage myeloproliferation and pleomorphic megakaryocytes
2. Serum erythropoietin level: Should be below normal range in PV
3. Endogenous erythroid colonies (if available)

Additional essential tests:

• Complete blood count with differential (assess for leukocytosis, thrombocytosis)
• Iron studies (iron deficiency can mask elevated hemoglobin in PV) 4
• Comprehensive metabolic panel
• Lactate dehydrogenase

Management Priorities

Immediate Actions:

1. If hematocrit >45-48%: Consider urgent phlebotomy to reduce thrombotic risk, particularly given the facial swelling suggesting possible thrombosis
2. Aspirin 81-100 mg daily: Start immediately unless contraindicated, as this reduces thrombotic events in PV
3. Hydration: Ensure adequate hydration to reduce blood viscosity

Risk Stratification:

Once PV is confirmed, classify as:

• High-risk: Age >60 years OR prior thrombosis → requires cytoreductive therapy (hydroxyurea)
• Low-risk: Age ≤60 years AND no prior thrombosis → phlebotomy + aspirin

Critical Pitfalls to Avoid

1. Do not dismiss elevated values as "high normal" without workup when accompanied by concerning symptoms like facial swelling
2. Do not delay thrombosis evaluation: Facial swelling in the context of polycythemia is a red flag for venous obstruction
3. Do not diagnose PV on Hb/Hct alone: Requires JAK2 mutation or two minor criteria 4
4. Do not forget iron studies: Iron deficiency can mask the true hemoglobin elevation in PV 4
5. Remember masked PV exists: Some patients have JAK2-positive PV with normal blood counts but present with thrombosis 1

The facial swelling transforms this from a routine polycythemia workup into an urgent evaluation for life-threatening complications.